Wednesday, July 18, 2012

Outgoing Impax CFO gets cash, health care benefits

Departing Impax Laboratories Inc. CFO Arthur Koch Jr. will take a hefty benefits package with him.
The Hayward-based generic drug maker (NASDAQ: IPXL) will pay Koch more than $1.15 million cash in equal installments over 12 months, according to a Securities and Exchange Commission filing Wednesday, as well as a lump sum cash payment of his pro rata target bonus for fiscal 2012 by March 15, 2013.

No comments:

Post a Comment